Comparative in vitro activity of ertapenem against bacterial pathogens isolated from patients with lower respiratory tract infections P.S. Hicks, B.

Slides:

Advertisements

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

Advertisements

Laboratory diagnosis and biosafety issues of biological warfare agents

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

Staphylococcus lugdunensis vertebral osteomyelitis

Gut bacterial microbiota and obesity

Approach to diagnosis of infective endocarditis

Herpes zoster in non-hospitalized children

Atypical respiratory pathogens

In vitro effects of cefotaxime and ceftriaxone on Salmonella typhi within human monocyte-derived macrophages B. Ekinci, A.Y. Coban, A. Birinci, B. Durupinar,

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

R. Cantón Clinical Microbiology and Infection

Link between intracellular pathogens and cardiovascular diseases

Louis Pasteur, from crystals of life to vaccination

How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development R. Bax Clinical Microbiology.

Non-antibiotic strategies for sepsis

P. Davey, C. Pagliari, A. Hayes Clinical Microbiology and Infection

Potential risk factors for infection with Candida spp

Nosocomial bloodstream infections in children: an 8-year experience at a tertiary-care hospital in Finland E. Sarvikivi, O. Lyytikäinen, M. Vaara, H.

How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach D. Guillemot Clinical Microbiology.

In vitro activity, postantibiotic effect and human monocyte activity of grepafloxacin against Legionella species Jacques Dubois, Claude St-Pierre Clinical.

Trends in antibiotic prescribing in general internal medicine wards: antibiotic use and indication for prescription B. Maraha, M. Bonten, H. Fiolet,

Holt Hanne M. , Søgaard Per , Gahrn-Hansen Bente

Vector control: a cornerstone in the malaria elimination campaign

Fourth-generation cephalosporins: a review of in vitro activity, pharmacokinetics, pharmacodynamics and clinical utility Javier Garau, Walter Wilson,

C-3′Quaternary Ammonium Cephems, a New Wave of Cephalosporins

Sofie Arens, Jan Verhaegen, Ludo Verbist

Multicenter study of the in vitro activity of cefepime in comparison with five other broad- spectrum antibiotics against clinical isolates of Gram-positive.

Training for the infectious diseases speciality in Norway

F. Grill, P. Muñoz, R. Jofre, E. Bouza

R. Karakus, K. Caglar, C. Aybay Clinical Microbiology and Infection

Laboratory diagnosis and biosafety issues of biological warfare agents

M. Roche, H. Humphreys, E. Smyth, J. Phillips, R. Cunney, E

Gastrointestinal and respiratory Mycobacterium avium colonization and development of disseminated infection in HIV-positive patients Giampietro Nardi,

Elements of design: the knowledge on which we build

In vitro selection of antibiotic resistance in Pseudomonas aeruginosa

Isolation rate, T-serotyping and susceptibility to antibiotics of Group A Streptococcus from pediatric infections in Athens* M. Kanellopoulou, A. Makri,

Metagenomics and probiotics

Effect of antioxidants on the immune response of Helicobacter pylori

Laboratory diagnosis of Clostridium difficile disease

N. Maggi-Solcà, C. Valsangiacomo, J.-C. Piffaretti

G.R. Davies Clinical Microbiology and Infection

Pathogenesis of catheter-related infections: lessons for new designs

Harmonised monitoring of antimicrobial resistance in Salmonella and Campylobacter isolates from food animals in the European Union S. Bronzwaer Clinical.

Community-acquired pneumonia: epidemiologic and clinical consideration

Newly identified respiratory viruses associated with acute lower respiratory tract infections in children in Lanzou, China, from 2006 to 2009 Y. Jin,

Pandemic lineages of extraintestinal pathogenic Escherichia coli

Training in infectious diseases and tropical medicine in Britain

Vaccinations against respiratory tract infections at Hajj

Clinical infection services—the Leiden experience

Ethan Rubinstein, Itzhak Levy Clinical Microbiology and Infection

Statin use and clinical outcomes among pneumonia patients

Clinical Microbiology and Infection

Evaluation of the performance of the Helico Blot 2

Overview of cefixime use in community-acquired infections

Sanford Chodosh Clinical Microbiology and Infection

Facilitating learning and change in physicians: Implications for a system of continuing medical education in Europe Robert D. Fox Clinical Microbiology.

Abstracts Clinical Microbiology and Infection

Modelling during an emergency: the 2009 H1N1 influenza pandemic

New oral cephalosporins in pediatric community-acquired infections

In vitro activity of evernimicin and selected antibiotics against methicillin-resistant staphylococci: a 24-country study R. Goering, C.-E. Nord, R.

In vitro activity of a new echinocandin, LY303366, and comparison with fluconazole, flucytosine and amphotericin B against Candida species† C.B. Moore,

Are we losing the fight against malaria one more time?

Susceptibility of multi-drug-resistant Pseudomonas aeruginosa in intensive care units: results from the European MYSTIC study group† H. Goossens Clinical.

G.C. Schito Clinical Microbiology and Infection

Joshua P. Metlay, Daniel E. Singer Clinical Microbiology and Infection

J.A. Pérez-Molina, F. Fernández Clinical Microbiology and Infection

Impact of antibiotic restrictions: the patient's perspective

Fernando Baquero, John F

Localized Mycobacterium avium complex infection in a patient on HAART

The future of diagnostic bacteriology

Presentation transcript:

Comparative in vitro activity of ertapenem against bacterial pathogens isolated from patients with lower respiratory tract infections P.S. Hicks, B. Pelak, G.L. Woods, K.F. Bartizal, M. Motyl Clinical Microbiology and Infection Volume 8, Issue 11, Pages 753-757 (November 2002) DOI: 10.1046/j.1469-0691.2002.00461.x Copyright © 2002 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 1 Distribution of ertapenem MIC values for bacterial pathogens isolated from patients with lower respiratory infections. Clinical Microbiology and Infection 2002 8, 753-757DOI: (10.1046/j.1469-0691.2002.00461.x) Copyright © 2002 European Society of Clinical Infectious Diseases Terms and Conditions